In cardiac electrophysiology, there exist many sources of inter-and intra-personal variability. These include variability in conditions and environment, and genotypic and molecular …
Z Li, BJ Ridder, X Han, WW Wu, J Sheng… - Clinical …, 2019 - Wiley Online Library
The International Council on Harmonization (ICH) S7B and E14 regulatory guidelines are sensitive but not specific for predicting which drugs are pro‐arrhythmic. In response, the …
S Dutta, KC Chang, KA Beattie, J Sheng… - Frontiers in …, 2017 - frontiersin.org
Drug-induced Torsade-de-Pointes (TdP) has been responsible for the withdrawal of many drugs from the market and is therefore of major concern to global regulatory agencies and …
Z Li, GR Mirams, T Yoshinaga… - Clinical …, 2020 - Wiley Online Library
This white paper presents principles for validating proarrhythmia risk prediction models for regulatory use as discussed at the In Silico Breakout Session of a Cardiac Safety Research …
The understanding of complex physical or biological systems nearly always requires a characterization of the variability that underpins these processes. In addition, the data used …
Computational models of cardiac electrophysiology have a long history in basic science applications and device design and evaluation, but have significant potential for clinical …
The importance of electrolyte concentrations for cardiac function is well established. Electrolyte variations can lead to arrhythmias onset, due to their important role in the action …
While cardiomyocytes differentiated from human induced pluripotent stems cells (hiPSCs) hold great promise for drug screening, the electrophysiological properties of these cells can …
C Jiang, E Richardson, J Farr, AP Hill, R Ullah… - The American Journal of …, 2022 - cell.com
Modern sequencing technologies have revolutionized our detection of gene variants. However, in most genes, including KCNH2, the majority of missense variants are currently …